CONSTELLATION PHARMACEUTICALS INC;Constellation Pharmaceuticals; Inc.
发明人:
申请号:
EP16719190.7
公开号:
EP3286172B1
申请日:
2016.04.22
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with LSD1. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with LSD1.